查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654302

全球全身影像市场：市场规模、份额、趋势分析（按方式、应用、最终用途和地区）、细分市场预测（2025-2030 年）

Whole Body Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Nuclear Imaging), By Application (Oncology, Trauma And Emergency Care, Metastasis Detection), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

全身成像市场规模与趋势：

预计 2024 年全球全身影像市场规模将达到 295.8 亿美元，2025 年至 2030 年的复合年增长率为 5.94%。

推动产业成长的关键因素包括快速的技术进步，从而提高诊断的准确性和效率。人们对预防筛检的认识不断提高，推动了对疾病早期发现和监测的需求。此外，癌症和心血管疾病等慢性疾病的发生率日益上升，需要先进的诊断影像解决方案。老龄化人口对各种健康状况的敏感度不断增加，也是全身成像技术越来越多地采用以便及时诊断和製定治疗计划的因素。

全身成像系统比局部成像技术更有效，因为它们只需一次扫描就能提供整个身体的全面视野。这样就无需对特定区域进行多次扫描，从而减少了患者重复检查的需要，并最大限度地减少了诊断延迟。这些系统在识别癌症等全身性疾病方面特别有效，因为必须评估跨多个器官的转移。它还有助于检测局部测试中可能遗漏的异常，例如隐藏的病变、血管疾病和影响多个器官的发炎疾病。

CT 和 MRI 技术的进步提高了成像精度、缩短了扫描时间并增加了患者的舒适度，进一步促进了市场的成长。高解析度成像、人工智慧诊断工具和先进的 3D影像处理功能等创新使得更早、更准确地检测复杂病理成为可能。此外，CT扫描中辐射剂量的降低和MRI扫描中造影效果的改善使得诊断更加安全、有效，进一步推动了其在广泛医疗应用中的应用。

癌症、心血管疾病、糖尿病、神经系统疾病等慢性病的发生率不断上升也是推动全身影像产业成长的主要因素。这些疾病通常需要持续监测和早期检测才能有效治疗，这导致对 CT 和 MRI 等先进成像技术的需求增加。全身影像在慢性疾病的诊断、分期和追踪进展中发挥着至关重要的作用，能够及时干预并改善患者预后，从而刺激市场扩张。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章全身影像市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 全身影像市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章全身影像市场：按方式的估计和趋势分析

  • 细分仪表板
  • 全身成像市场的波动
  • 全身影像市场：按方式分類的市场规模预测和趋势分析（2018-2030 年）
  • 电脑断层扫描 (CT)
  • 磁振造影（MRI）
  • 核子造影
  • 其他方式

第 5 章全身影像市场：按应用分類的估计和趋势分析

  • 细分仪表板
  • 全身成像市场波动分析
  • 全身影像市场：按应用分類的市场规模预测和趋势分析（2018-2030 年）
  • 肿瘤学
  • 创伤与急救医学
  • 转移检测
  • 全身健康检查

第六章全身影像市场：依最终用途的估计与趋势分析

  • 细分仪表板
  • 全身成像市场的波动
  • 全身影像市场：按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
  • 医院
  • 诊断影像中心
  • 其他最终用户

7. 全身影像市场：区域估计和趋势分析（按技术、应用和最终用途）

  • 各地区市场占有率（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 主要企业市场占有率分析（2024年）
  • 公司地位分析
  • 公司分类（新兴企业、创新者、领导者）
  • 公司简介
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Canon Medical Systems
    • Fujifilm Holdings Corporation
    • Mediso Ltd.
    • NeuroLogica (a subsidiary of Samsung Electronics)
    • United Imaging Healthcare
    • Shimadzu Corporation
Product Code: GVR-4-68040-502-8

Whole Body Imaging Market Size & Trends:

The global whole body imaging market size was valued at USD 29.58 billion in 2024 and is expected to grow at a CAGR of 5.94% from 2025 to 2030. Major factors driving the growth of the industry include rapid technological advancements that enhance diagnostic accuracy and efficiency. Rising awareness of preventive health checkups is fueling demand for early detection and monitoring of diseases. Additionally, the growing prevalence of chronic disorders such as cancer and cardiovascular diseases necessitates advanced imaging solutions. The aging population, being more prone to various health conditions, further contributes to the increased adoption of whole-body imaging technologies for timely diagnosis and treatment planning.

Whole-body imaging systems are more efficient than localized imaging techniques as they offer a comprehensive view of the entire body in a single session. This eliminates the need for multiple scans targeting specific regions, reducing patient exposure to repeated procedures and minimizing diagnostic delays. These systems are particularly effective in identifying systemic diseases such as cancer, where metastatic spread across multiple organs must be assessed. They also aid in detecting abnormalities that might be overlooked in regional scans, such as hidden lesions, vascular conditions, or inflammatory diseases affecting multiple systems.

Technological advancements in CT and MRI are further contributing to market growth as they enhance imaging precision, reduce scan times, and improve patient comfort. Innovations such as high-resolution imaging, AI-powered diagnostic tools, and advanced 3D imaging capabilities enable early and accurate detection of complex conditions. Additionally, reduced radiation doses in CT and improved contrast imaging in MRI ensure safer and more effective diagnostic procedures, further driving their adoption across diverse medical applications.

The increasing prevalence of chronic disorders, such as cancer, cardiovascular diseases, diabetes, and neurological conditions, is also a key factor contributing to the growth of the whole-body imaging industry. As these diseases often require ongoing monitoring and early detection for effective management, the demand for advanced imaging technologies like CT and MRI rises. Whole-body imaging plays a crucial role in diagnosing, staging, and tracking the progression of chronic disorders, allowing for timely interventions and improved patient outcomes, thereby fueling market expansion.

Global Whole Body Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global whole body imaging market report on the basis of modality, application, end-use, and region:

  • Modality Outlook (Revenue, USD Million, 2018 - 2030)
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
  • Other Modalities
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Trauma & Emergency Care
  • Metastasis Detection
  • Full-Body Health Screenings
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Whole Body Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic diseases requiring comprehensive diagnostic imaging
      • 3.2.1.2. Advancements in imaging technologies
      • 3.2.1.3. Growing demand for early and accurate disease diagnosis
      • 3.2.1.4. Expanding applications of whole-body imaging in oncology, cardiology, and neurology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced whole-body imaging systems
      • 3.2.2.2. Limited reimbursement and insurance coverage
      • 3.2.2.3. Limited availability of skilled healthcare professionals
  • 3.3. Whole Body Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Whole Body Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Whole Body Imaging Modality Market Movement Analysis
  • 4.3. Global Whole Body Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Computed Tomography (CT)
    • 4.4.1. Computed tomography (CT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Magnetic Resonance Imaging (MRI)
    • 4.5.1. Magnetic resonance imaging (MRI) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Nuclear Imaging
    • 4.6.1. Nuclear imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other Modalities
    • 4.7.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Whole Body Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Whole Body Imaging Application Market Movement Analysis
  • 5.3. Global Whole Body Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Trauma and Emergency Care
    • 5.5.1. Trauma and emergency care market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Metastasis Detection
    • 5.6.1. Metastasis detection market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Full-Body Health Screenings
    • 5.7.1. Full-body health screenings market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Whole Body Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Whole Body Imaging End Use Market Movement Analysis
  • 6.3. Global Whole Body Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other End Users
    • 6.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Whole Body Imaging Market: Regional Estimates & Trend Analysis By Technology, Application, End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. GE HealthCare
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Koninklijke Philips N.V.
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Siemens Healthineers AG
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Canon Medical Systems
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Fujifilm Holdings Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Mediso Ltd.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. NeuroLogica (a subsidiary of Samsung Electronics)
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. United Imaging Healthcare
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Shimadzu Corporation
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4. North America whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5. North America whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 6. North America whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 8. U.S. whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 9. U.S. whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11. Canada whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 12. Canada whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 13. Mexico whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14. Mexico whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 15. Mexico whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 16. Europe whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 17. Europe whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18. Europe whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 19. Europe whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 20. UK whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 21. UK whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 22. UK whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23. Germany whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24. Germany whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 25. Germany whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 26. France whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 27. France whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 28. France whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29. Italy whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 30. Italy whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 31. Italy whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32. Denmark whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33. Denmark whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 34. Denmark whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 35. Sweden whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 36. Sweden whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 37. Sweden whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38. Norway whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39. Norway whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 40. Norway whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 45. Japan whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46. Japan whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 47. Japan whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 48. China whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 49. China whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 50. China whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51. India whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 52. India whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 53. India whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54. Australia whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55. Australia whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 56. Australia whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 57. South Korea whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 58. South Korea whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 59. South Korea whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60. Thailand whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61. Thailand whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 62. Thailand whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 63. Latin America whole body imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 64. Latin America whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 65. Latin America whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 66. Latin America whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 67. Brazil whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 68. Brazil whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 69. Brazil whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 70. Argentina whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 71. Argentina whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 72. Argentina whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 73. Middle East & Africa whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 74. Middle East & Africa whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 77. South Africa whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 78. South Africa whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 79. South Africa whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 80. Saudi Arabia whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 83. UAE whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 84. UAE whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 85. UAE whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 86. Kuwait whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 87. Kuwait whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 88. Kuwait whole body imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Whole body imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Whole body imaging market driver impact
  • Fig. 19 Whole body imaging market restraint impact
  • Fig. 20 Whole body imaging market: Modality movement analysis
  • Fig. 21 Whole body imaging market: Modality outlook and key takeaways
  • Fig. 22 Computed tomography (CT) market estimates and forecast, 2018 - 2030
  • Fig. 23 Magnetic resonance imaging (MRI) market estimates and forecast, 2018 - 2030
  • Fig. 24 Nuclear imaging market estimates and forecast, 2018 - 2030
  • Fig. 25 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 26 Whole body imaging market: Application movement analysis
  • Fig. 27 Whole body imaging market: Application outlook and key takeaways
  • Fig. 28 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 29 Trauma and emergency care market estimates and forecast, 2018 - 2030
  • Fig. 30 Metastasis detection market estimates and forecast, 2018 - 2030
  • Fig. 31 Full-body health screenings market estimates and forecast, 2018 - 2030
  • Fig. 32 Whole body imaging market: End use movement analysis
  • Fig. 33 Whole body imaging market: End use outlook and key takeaways
  • Fig. 34 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 35 Diagnostic imaging centers market estimates and forecast, 2018 - 2030
  • Fig. 36 Other end users market estimates and forecast, 2018 - 2030
  • Fig. 37 Global whole body imaging market: Regional movement analysis
  • Fig. 38 Global whole body imaging market: Regional outlook and key takeaways
  • Fig. 39 North America
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S.
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Mexico
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 47 Europe
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 49 UK
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France
  • Fig. 54 France market estimates and forecasts, 2018 - 2030
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 59 Denmark
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 61 Sweden
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 63 Norway
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 67 China
  • Fig. 68 China market estimates and forecasts, 2018 - 2030
  • Fig. 69 Japan
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 71 India
  • Fig. 72 India market estimates and forecasts, 2018 - 2030
  • Fig. 73 Thailand
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 75 South Korea
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 77 Australia
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 79 Latin America
  • Fig. 80 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 81 Brazil
  • Fig. 82 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 83 Argentina
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 85 Middle East and Africa
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Africa
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 91 UAE
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 93 Kuwait
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players- Whole body imaging market